Pathway Financial Advisers’s Elevance Health ELV Stock Holding History

Pathway Financial Advisers’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$262K	Buy	+678	New	+$251K	0.07%	160
2026 Q1	–	Sell	-678	Closed	-$238K	–	169
2025 Q4	$238K	Hold	678	–	–	0.07%	150
2025 Q3	$219K	Buy	678 +1	+0.1%	+$311	0.06%	152
2025 Q2	$263K	Hold	677	–	–	0.09%	147
2025 Q1	$294K	Sell	677 -607	-47%	-$244K	0.1%	139
2024 Q4	$474K	Sell	1,284 -656,323	-100%	-$275M	0.16%	126
2024 Q3	$1.26K	Buy	657,607 +656,344	+51,967%	+$351M	﹤0.01%	369
2024 Q2	$677K	Buy	1,263 +15	+1%	+$7.93K	0.24%	108
2024 Q1	$647K	Buy	1,248 +9	+0.7%	+$4.48K	0.23%	112
2023 Q4	$584K	Buy	1,239 +74	+6%	+$34.2K	0.22%	113
2023 Q3	$508K	Buy	+1,165	New	+$528K	0.21%	114
2023 Q1	$527K	Sell	1,146 -38	-3%	-$18.1K	0.21%	110
2022 Q4	$608K	Buy	+1,184	New	+$601K	0.25%	102

Other funds holding ELV

AACR

ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return

HGIM

High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Focused Investors Los Angeles, California $2.96B AUM 15.6% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Pathway Financial Advisers's ELV Position: Q2 2026 in Review

Pathway Financial Advisers opened a new position in Elevance Health (ELV) in Q2 2026: 678 shares worth $262K. The stake represents 0.07% of the portfolio and ranks #160 among its holdings. This is a return to the name: Pathway Financial Advisers previously reported a position in ELV as recently as Q4 2025.

Pathway Financial Advisers first reported a position in ELV in Q4 2022 and has held it in 13 quarters since. The position peaked at $677K in Q2 2024. 637 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Pathway Financial Advisers held 678 shares of Elevance Health worth $262K as of Q2 2026.
Elevance Health was a new Pathway Financial Advisers position in Q2 2026.
Elevance Health made up 0.07% of Pathway Financial Advisers's portfolio in Q2 2026, its #160 holding.
Pathway Financial Advisers first reported a position in Elevance Health in Q4 2022 and has held it in 13 quarters since.
Pathway Financial Advisers's Elevance Health position peaked at $677K in Q2 2024.
637 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Pathway Financial Advisers's 13F filing for Q2 2026, filed 30 Jul 2026.